ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT

Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT explained in plain language.

Never miss a new study

Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT trials appear

Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Genetically modified goat milk tested to protect cancer patients after transplant

Disease control Recruiting now

This early-stage study is testing whether drinking milk from genetically engineered goats can help prevent a dangerous complication called graft-versus-host disease (GVHD) in blood cancer patients. The milk contains a human enzyme that may promote healthy gut bacteria and reduce …

Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT

Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENT trials appear

Genetically modified goat milk tested to protect cancer patients after transplant